Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 5, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Catalase: Antioxidant Treatment for COVID-19

Britannia Food Technologist – Production Officer (Bread) Recruitment

SACON Research Biologist & Programme Officer Job Recruitment

Catalase: Antioxidant Treatment for COVID-19
  • BiotechToday
  • World

Catalase: Antioxidant Treatment for COVID-19

bioxone October 2, 2020October 1, 2020

-Thota Kanishka Rao, Amity University Kolkata

Researchers have discovered that a drug, Catalase, might be the solution to the ongoing coronavirus pandemic. Catalase is a naturally occurring enzyme having the potential as a therapeutic drug treat COVID-19 symptom and suppress the replication of the virus inside the body.

Catalase is produced naturally and employed by humans, animals and plants. Inside cells, the antioxidant enzyme catalyst launches the breakdown of hydrogen peroxide, which can be poisonous, into water and oxygen. The catalyst is likewise normally utilised worldwide in food production and as a dietary enhancement.

Three types of tests, addressing different symptoms of COVID-19 were conducted. To begin with, they exhibited the enzymes anti-inflammatory impacts and its capacity to direct the creation of cytokines, a protein produced in white blood cells. Cytokines are a significant aspect of the human immune system, yet they can likewise signal the immune system to attack the body’s cells if too many are produced—a supposed ‘cytokine storm’ that is accounted for in certain patients determined to have COVID-19.

Secondly, the team indicated that catalase can secure alveolar cells, which line the human lungs, from damage because of oxidation. Finally, the tests indicated that catalase can subdue the replication of SARS-CoV-2 infection in rhesus macaques, a type of monkey, without observable harmfulness.

This research has far-reaching implications beyond the treatment of COVID-19. Cytokine storm may be a lethal condition which will complicate other infections, like influenza, still as non-infectious conditions, like an autoimmune disease.

Also read: Efficacy of the two PCR kits for SARS-CoV-2 nucleic acid Detection

Source:

Meng Qin et al, An Antioxidant Enzyme Therapeutic for COVID‐19, Advanced Materials (2020). DOI: 10.1002/adma.202004901

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged anti-inflammation antioxidant treatment Catalase covid treatment COVID-19 Enzyme immunosuppression SARS-CoV-2

One thought on “Catalase: Antioxidant Treatment for COVID-19”

  1. Bidisha Si says:
    October 2, 2020 at 9:38 am

    Great 👍

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Job and Internship
  • Signaling Pathway

SACON Research Biologist & Programme Officer Job Recruitment

bioxone October 2, 2020

-Shristi Sharma, Team bioXone Master’s degree with a botany/zoology background are eligible to apply for Programme Officer & Biologist positions. SACON is recruiting msc botany/ zoology candidates with relevant eligibility are encouraged to walk-in for the positions below:  Advt. No. SACON/RES/RSCHRS-SELECTION, 04/2020 Post I Name of the Position: Junior Research Biologist (07 Nos) Project title: […]

Related Post

  • BiotechToday
  • World

World Malaria Day 2021- Let’s aim at “Reaching the Zero Malaria Target”

bioxone April 25, 2021April 24, 2021

Anannya Roy, Amity University Kolkata World Malaria Day (WMD) is celebrated every year on the 25th of April and it is a global effort to control the spread of Malaria. This day began to be officially observed in the year 2007 by the 60th session of the World Health Assembly, which serves as the WHO’s […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Understanding Cancer pathophysiology via isotopic tracing

bioxone July 14, 2021July 14, 2021

Kanikah Mehndiratta, MSc, University of Glasgow Cancer pathophysiology and devising its treatment approaches have been major areas of interest for scientists and doctors globally. Understanding cancer pathophysiology could help in checking for vulnerabilities and targeting the tumour therapeutically. To identify such metabolic pathways, metabolites need to be identified and/or quantified using tracing methods such as […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

The Genetics of Glaucoma in Africa

bioxone July 11, 2021July 11, 2021

Saakshi Bangera, DY Patil School of Biotechnology and Bioinformatics Primary open-angle glaucoma (POAG) is the most generic subtype of irreversible blindness. Primary open-angle glaucoma primarily affects the people of African heritage. Among Europeans, the prevalence of POAG is approximately 1%, whereas, in African-Americans, this value ranges between 4-5%. Additionally, individuals of African ancestry experience an […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy